Arctic Bioscience AS (STU:9TD) Total Operating Expense: €3.84 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:9TD Arctic Bioscience AS STU:9TD
55 GF Score
Price €0.19
GF Value €0.29
! 7 Warning Signs
View Full Analysis

What is Arctic Bioscience AS Total Operating Expense?

Arctic Bioscience AS STU:9TD +52.05% 55 Total Operating Expense is €3.84 Mil as of Jun. 2026. GuruFocus rates STU:9TD with a GF Score™ of 55/100 and a GF Value™ of €0.29. The stock has 7 warning signs investors should review.

Arctic Bioscience AS's Total Operating Expense for the six months ended in Jun. 2026 was €1.93 Mil. Arctic Bioscience AS's Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was €3.84 Mil.

Arctic Bioscience AS Total Operating Expense Related Terms

Arctic Bioscience AS Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Arctic Bioscience AS's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arctic Bioscience AS Total Operating Expense Chart

Arctic Bioscience AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial 4.51 4.69 5.07 5.08 3.76

Arctic Bioscience AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.57 2.58 1.89 1.91 1.93
STU:9TD
55GF Score
Arctic Bioscience AS STU:9TD
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arctic Bioscience AS Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €3.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €3.84 Mil mean?
Arctic Bioscience AS (STU:9TD) has a Total Operating Expense of €3.84 Mil as of Jun. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Arctic Bioscience AS and its competitors.
Is Arctic Bioscience AS's Total Operating Expense too high?
Arctic Bioscience AS's current Total Operating Expense is €3.84 Mil. Overall, Arctic Bioscience AS has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Arctic Bioscience AS's Total Operating Expense compare to VRTX and REGN?
Arctic Bioscience AS's Total Operating Expense of €3.84 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Arctic Bioscience AS and its competitors. Arctic Bioscience AS's current Total Operating Expense is €3.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arctic Bioscience AS stock overvalued right now?
Arctic Bioscience AS (STU:9TD) has a current Total Operating Expense of €3.84 Mil. The stock's GF Value™ is €0.29, compared to a current price of €0.19 — trading 36% below its estimated fair value. The current Total Operating Expense is €3.84 Mil. Arctic Bioscience AS's overall GF Score™ is 55/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Arctic Bioscience AS (STU:9TD), the current Total Operating Expense is €3.84 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arctic Bioscience AS (STU:9TD) Overvalued in 2026?

Based on GuruFocus' analysis, Arctic Bioscience AS stock appears to be undervalued. The current stock price of €0.19 is trading 36% below its estimated GF Value™ of €0.29.

Key valuation signals for STU:9TD:

  • Total Operating Expense: €3.84 Mil
  • GF Value™: €0.29 vs. price of €0.19 (36% below fair value)
  • GF Score™: 55/100 with 7 warning signs

No single metric tells the full story. See the STU:9TD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arctic Bioscience AS Business Description

Other Exchanges ABS:Norway9TD:Germany
Address Industrivegen 42, Orsta, NOR, 6155
Arctic Bioscience AS is a clinical-stage biotechnology company working to develop drug candidates within the areas of autoimmune and inflammatory diseases. It is developing pharmaceutical and commercializing nutraceutical products based on bioactive marine compounds, including lipids essential to maintaining cell membranes. The company's proprietary extraction technology is used to extract membrane fats from marine raw materials, such as herring roe and algae. Geographically, the company operates in Norway, the Americas, Europe, and APAC, with the majority of the revenue derived from the Americas.
55GF Score

Get the complete analysis for STU:9TD

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.19
Price
€0.29
GF Value